Gensciences

company

About

Gensciences develops drugs that focus on underserved illnesses like hemophilia, metabolic diseases, and anti-tumor fields.

  • 251 - 500

Details

Last Funding Type
Series A
Industries
Biotechnology,Clinical Trials,Health Care,Pharmaceutical,Product Research
Founded date
Jan 1, 2019
Number Of Employee
251 - 500
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
Gensciences has raised a total of — in funding over 2 rounds. Their latest funding was raised on Mar 4, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 4, 2021 Series A 1 Detail
Mar 4, 2021 Series B 1 Haitong Kaiyuan Investment Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Gensciences is funded by 2 investors. Haitong Kaiyuan Investment and Hygeia Capital LLC are the most recent investors.
Investor Name Lead Investor Funding Round
Haitong Kaiyuan Investment Yes Series B
Hygeia Capital LLC Series A